Home › Research › Prevention and risk
Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement
Bettina Heidecker, Peter Libby, Vassilios S. Vassiliou, François Roubille, Orly Vardeny, Christian Hassager, Michael Athanassios Gatzoulis, Mamas A. Mamas et al.. European Heart Journal, 2025-05-27
Topic: Risk, prevention and care in population studies
Plain-language summary
Vaccination is increasingly acknowledged as an effective preventive measure not only against specific infections, but also for the prevention of cardiovascular disease in high-risk patients. Specifically, a growing body of evidence suggests that vaccines against influenza, SARS-CoV-2, respiratory syncytial virus, herpes zoster, and other viruses significantly reduce infection and for influenza the incidence of major adverse cardiovascular events in vaccinated individuals. This clinical consensus statement examines the existing literature and accumulated evidence and offers practical clinical advice on vaccination timing and target demographics, specifically addressing complex clinical scenarios with a focus on cardiovascular conditions. It includes guidelines for vaccinating vulnerable populations such as immunosuppressed individuals, patients with congenital heart disease, and pregnant women as well as safety and potential complications of the procedure.
What this study adds
Evidence grade: Low
This consensus statement is about vaccination as cardiovascular prevention, not Alzheimer's disease, so it provides no information on Alzheimer's treatment, cure or prevention. It notes evidence that influenza vaccination reduces major adverse cardiovascular events in vaccinated individuals.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Heidecker, B., Libby, P., Vassiliou, V. S., Roubille, F., Vardeny, O., Hassager, C., et al. (2025). Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. European Heart Journal. https://doi.org/10.1093/eurheartj/ehaf384
Vancouver
Heidecker B, Libby P, Vassiliou VS, Roubille F, Vardeny O, Hassager C, et al. Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. European Heart Journal. 2025. doi:10.1093/eurheartj/ehaf384. PMID: 40582710.
BibTeX
@article{heidecker2025-40582710,
author = {Heidecker, Bettina and Libby, Peter and Vassiliou, Vassilios S. and Roubille, François and Vardeny, Orly and Hassager, Christian and Gatzoulis, Michael Athanassios and Mamas, Mamas A. and others},
title = {{Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement}},
journal = {European Heart Journal},
year = {2025},
doi = {10.1093/eurheartj/ehaf384},
pmid = {40582710},
url = {https://doi.org/10.1093/eurheartj/ehaf384}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Specifically, a growing body of evidence suggests that vaccines against influenza, SARS-CoV-2, respiratory syncytial virus, herpes zoster, and other viruses significantly reduce infection and for influenza the incidence of major adverse cardiovascular events in vaccinated individuals.
Why it matters
This consensus statement is about vaccination as cardiovascular prevention, not Alzheimer's disease, so it provides no information on Alzheimer's treatment, cure or prevention. It notes evidence that influenza vaccination reduces major adverse cardiovascular events in vaccinated individuals.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 55/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (European Heart Journal) |
| Journal's citation record | 3 / 4 | European Heart Journal: journal h-index 456 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 76 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 25.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 6 / 6 | Cited 84.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 76 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Thomas Felix Lüscher: h-index 160 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Brigham and Women's Hospital: institution h-index 1,995 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 20 institution(s) in 8 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40582710) |
| Free to read | 2 / 2 | Free to read |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1093/eurheartj/ehaf384
- PubMed: 40582710
- Original source →
- Free full text: European Heart Journal →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Prevention and risk from nearby years
Also in Prevention and risk
269 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.